Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31294924 | 1.00 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL29292298 | 1.00 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL7927514 | 0.92 | ALDH1A1 (0.53) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2047105 | 0.92 | ALDH1A1 (0.53) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL19678473 | 0.92 | ALDH1A1 (0.53) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL30530210 | 0.92 | ALDH1A1 (0.53) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL3689815 | 0.90 | ALDH1A1 (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL31563027 | 0.90 | MAPT (0.58) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL29054903 | 0.90 | MAPT (0.58) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL29016127 | 0.90 | MAPT (0.58) | PRKCAPRKCEPRKCQPRKCDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116615179-A | Composition for forming coating film | 花王株式会社 | 2023-08-18 | — | — | CN | claimed |
| CN-116615179-B | Composition for forming coating film | 花王株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-122055124-A | Cosmetic comprising hydrophobicized powder | 株式会社资生堂 | 2026-05-15 | — | — | CN | disclosed |
| EP-3888753-B1 | COATING FILM FOR SKIN | KAO CORP (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12280127-B2 | Composition for forming coating film | KAO CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| CN-119584950-A | Oil-in-water emulsion composition | 花王株式会社 | 2025-03-07 | — | — | CN | disclosed |
| CN-119173244-A | Composition for forming coating film | 花王株式会社 | 2024-12-20 | — | — | CN | disclosed |
| CN-119156197-A | Composition for forming coating film | 花王株式会社 | 2024-12-17 | — | — | CN | disclosed |
| CN-113164800-B | Detergent composition | 株式会社资生堂 | 2024-11-22 | — | — | CN | disclosed |
| CN-118717558-A | Oil-in-water type emulsified cosmetic | 株式会社资生堂 | 2024-10-01 | — | — | CN | disclosed |
| US-20070031358-A1 | Cosmetic formulations comprising diketo diphenyl pyrrolo-pyrrole pigments | CIBA SPECIALTY CHEMICALS CORP. | 2007-02-08 | — | — | US | disclosed |
| US-20070031353-A1 | Cosmetic formulations comprising diketo diphenyl pyrrolo-pyrrole pigments | CIBA SPECIALTY CHEMICALS CORP. | 2007-02-08 | — | — | US | disclosed |
| EP-1739095-A1 | CATION-MODIFIED PURIFIED GALACTOMANNAN POLYSACCHARIDE AND COSMETIC COMPOSITION CONTAINING THE SUBSTANCE | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-20060275235-A1 | Cation-modified galactomannan polysaccharide and cosmetic composition containing the same | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1630176-A1 | CATION-MODIFIED GALACTOMANNAN POLYSACCHARIDE AND COSMETIC COMPOSITION CONTAINING THE SAME | TOHO CHEMICAL INDUSTRY CO., LTD. (JP) | 2006-03-01 | — | — | EP | disclosed |
| US-20030180335-A1 | Skin treatment composition | BUXOM US BUYER LLC | 2003-09-25 | — | — | US | disclosed |
| EP-1283031-A2 | Skin treatment composition | Shiseido Co., Ltd. (JP) | 2003-02-12 | — | — | EP | disclosed |
| EP-1137390-A1 | COSMETIC PREPARATIONS CONTAINING ORGANIC PIGMENTS FROM THE CLASS OF PYRROLO- 3,4-C]-PYRROLES | Ciba SC Holding AG (CH) | 2001-10-04 | — | — | EP | disclosed |
| WO-2000033795-A1 | COSMETIC PREPARATIONS CONTAINING ORGANIC PIGMENTS FROM THE CLASS OF PYRROLO-[3,4-C]-PYRROLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-06-15 | — | — | WO | disclosed |
| EP-0277244-B1 | SPHERICAL CLAY MINERAL POWDER, PROCESS FOR ITS PRODUCTION, AND COMPOSITION CONTAINING SAME | SHISEIDO CO LTD (JP) | 1994-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180335-A1 | Skin treatment composition | OXER1, CUTA, HRH2 | PRKCA 4003/4885PRKCE 3377/4885PRKCQ 4043/4885 |
| US-20070031358-A1 | Cosmetic formulations comprising diketo diphenyl pyrrolo-pyrrole pigments | TYR, LAGE3, KRT18 | PRKCA 1944/4885PRKCE 1215/4885PRKCQ 694/4885 |
| US-20060275235-A1 | Cation-modified galactomannan polysaccharide and cosmetic composition containing the same | FUT6, FUT5, FUCA1 | PRKCA 1917/4885PRKCE 1887/4885PRKCQ 1165/4885 |
| US-20070031353-A1 | Cosmetic formulations comprising diketo diphenyl pyrrolo-pyrrole pigments | TYR, KRT18, LAGE3 | PRKCA 1976/4885PRKCE 1270/4885PRKCQ 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.